Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

AIMA Hong Kong supports Financial Services Development Council initiative

Monday, November 18, 2013
Opalesque Industry Update - AIMA Hong Kong, the local branch of the Alternative Investment Management Association (AIMA), the global hedge fund industry association, has expressed its support for the Hong Kong Financial Services Development Council’s vision for Hong Kong as a pre-eminent international financial and asset management centre.

The six FSDC reports published today provide a framework of research and recommendations that address many of the challenges and opportunities that Hong Kong faces, amidst a highly competitive regional and global environment.

The development of a broader and deeper range of asset classes and product types will ensure that Hong Kong attracts new asset management flows and remains an attractive base for talent, all of which will increase the economic activities of the financial sector and its overall contribution to Hong Kong.

In particular, AIMA Hong Kong welcomes the development of an OEIC regime and advocates a competitive tax and regulatory framework as well as one that recognizes the importance of cost and process efficiencies in attracting asset managers to Hong Kong.

Philip Tye, Chairman of AIMA Hong Kong said, “The FSDC publications cover a broad range of initiatives which ensure that Hong Kong not only recognizes its strength as a global financial centre, but also builds on its position in the face of global and regional competition. Whilst Hong Kong is seen as a preeminent location for hedge funds in Asia, a holistic approach to taxation, regulation and environmental factors is important for the further development of the industry here in Hong Kong.”

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for